Atlas Trials

Validation of the Second Generation of the Controlled Attenuation Parameter (CAP) Using the MRI-PDFF as Reference

Clinical trial NCT03704792 · COMPLETED

Trial details

NCT number
NCT03704792
Sponsor
Echosens
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Chronic Liver Disease
Start date
2019-09-24
Primary completion
2021-11-30
Enrollment
207

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.